Alexandros Diamantidis
Board Member
Pharmaceutical Sciences
Zestagen
Switzerland
Biography
He has more than 35 years of investment and corporate experience in the life sciences industry. Mr. Diamantidis is the President of the Board of Bioanalytica SA, a marketing, sales and research biotechnology company that operates successfully since 1994. Bioanalytica SA has developed Zestagen’s antibodies up to the present preclinical stage.
Research Interest
Pharmaceutical Sciences
